The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer

Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiati...

Descripción completa

Detalles Bibliográficos
Autores principales: Blood, Paul A, Pickles, Tom
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887532/
https://www.ncbi.nlm.nih.gov/pubmed/17511871
http://dx.doi.org/10.1186/1748-717X-2-17
_version_ 1782133671046676480
author Blood, Paul A
Pickles, Tom
author_facet Blood, Paul A
Pickles, Tom
author_sort Blood, Paul A
collection PubMed
description Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer. This study used the provincial cancer registry in British Columbia, Canada, to determine median non-prostate cancer survival for men who were aged 75 to 82 years at start of radiation treatment. Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment. This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.
format Text
id pubmed-1887532
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18875322007-06-05 The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer Blood, Paul A Pickles, Tom Radiat Oncol Research Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer. This study used the provincial cancer registry in British Columbia, Canada, to determine median non-prostate cancer survival for men who were aged 75 to 82 years at start of radiation treatment. Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment. This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment. BioMed Central 2007-05-18 /pmc/articles/PMC1887532/ /pubmed/17511871 http://dx.doi.org/10.1186/1748-717X-2-17 Text en Copyright © 2007 Blood and Pickles; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Blood, Paul A
Pickles, Tom
The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer
title The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer
title_full The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer
title_fullStr The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer
title_full_unstemmed The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer
title_short The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer
title_sort median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887532/
https://www.ncbi.nlm.nih.gov/pubmed/17511871
http://dx.doi.org/10.1186/1748-717X-2-17
work_keys_str_mv AT bloodpaula themediannonprostatecancersurvivalismorethan10yearsformenuptoage80yearswhoareselectedandreceivecurativeradiationtreatmentforprostatecancer
AT picklestom themediannonprostatecancersurvivalismorethan10yearsformenuptoage80yearswhoareselectedandreceivecurativeradiationtreatmentforprostatecancer
AT bloodpaula mediannonprostatecancersurvivalismorethan10yearsformenuptoage80yearswhoareselectedandreceivecurativeradiationtreatmentforprostatecancer
AT picklestom mediannonprostatecancersurvivalismorethan10yearsformenuptoage80yearswhoareselectedandreceivecurativeradiationtreatmentforprostatecancer

Ejemplares similares